Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Top Cited Papers
- 28 October 2005
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 310 (5748) , 644-648
- https://doi.org/10.1126/science.1117679
Abstract
Recurrent chromosomal rearrangements have not been well characterized in common carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression. Two ETS transcription factors, ERG and ETV1 , were identified as outliers in prostate cancer. We identified recurrent gene fusions of the 5′ untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression. By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1 . Cell line experiments suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer. These results have implications in the development of carcinomas and the molecular diagnosis and treatment of prostate cancer.Keywords
This publication has 29 references indexed in Scilit:
- The development of imatinib as a therapeutic agent for chronic myeloid leukemiaBlood, 2005
- Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptomeOncogene, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during pubertyThe FASEB Journal, 2004
- A census of human cancer genesNature Reviews Cancer, 2004
- Ets proteins in biological control and cancerJournal of Cellular Biochemistry, 2004
- Classification of pediatric acute lymphoblastic leukemia by gene expression profilingBlood, 2003
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Molecular characterisation of soft tissue tumours: a gene expression studyThe Lancet, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001